Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, Observational Study of Entecavir to Assess Long-term Outcomes
2005-003284-22Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Chronic Hepatitis B (CHB) comparing Entecavir with Other standard-of-care HBV nucleos(t)ide analogues (2 arms). Primary endpoint: Long-term clinical outcomes. Started Feb 2007; status: completed.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2005-003284-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003284-22.